The flavonoid quercetin in disease prevention and therapy: Facts and fancies

Biochemical Pharmacology

Volumn 83, Issue 1, 2012, Pages 6-15

  Russo, Maria ^a   Spagnuolo, Carmela ^a   Tedesco, Idolo ^a   Bilotto, Stefania ^a   Russo, Gian Luigi ^a  

^a CNR   (Italy)

Author keywords

Antioxidant; Bioavailability; Cancer; Cardiovascular disease; Phytochemicals; Quercetin

Indexed keywords

ASCORBIC ACID; BETA CATENIN; CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NANOCRYSTAL; NATURAL KILLER CELL RECEPTOR NKG2D; NICOTINIC ACID; QUERCETIN; STROMELYSIN; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTERIAL PRESSURE; ARTERIOSCLEROSIS; AUTOPHAGY; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN MCF 7; COLON ADENOCARCINOMA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ABSORPTION; DRUG BINDING SITE; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SAFETY; ENDOPLASMIC RETICULUM STRESS; GENOTOXICITY; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; IC 50; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LUNG CANCER; MUTAGENICITY; NATURAL KILLER CELL; NEPHROTOXICITY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; REVIEW; SENESCENCE; SINGLE DRUG DOSE; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE;

EID: 81855164783     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.08.010     Document Type: Note

References (100)

1. G.L. Russo Ins and outs of dietary phytochemicals in cancer chemoprevention Biochem Pharmacol 74 2007 533 544
2. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer 3 2003 768 780
3. P.M. Kris-Etherton, M. Lefevre, G.R. Beecher, M.D. Gross, C.L. Keen, and T.D. Etherton Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis Annu Rev Nutr 24 2004 511 538
4. J. Kim, H.J. Lee, and K.W. Lee Naturally occurring phytochemicals for the prevention of Alzheimer's disease J Neurochem 112 2010 1415 1430
5. K.W. Lee, A.M. Bode, and Z. Dong Molecular targets of phytochemicals for cancer prevention Nat Rev Cancer 11 2011 211 218
6. P. Boffetta, E. Couto, J. Wichmann, P. Ferrari, D. Trichopoulos, and H.B. Bueno-de-Mesquita Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst 102 2010 529 537
7. F.L. Crowe, A.W. Roddam, T.J. Key, P.N. Appleby, K. Overvad, and M.U. Jakobsen Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study Eur Heart J 32 2011 1235 1243
8. C. Fimognari, and P. Hrelia Sulforaphane as a promising molecule for fighting cancer Mutat Res 635 2007 90 104
9. A. Tarozzi, F. Morroni, A. Merlicco, S. Hrelia, C. Angeloni, and G. Cantelli-Forti Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line J Neurochem 111 2009 1161 1171
10. M.G. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, and F. Fidanza Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study Arch Intern Med 155 1995 381 386
11. M. Harwood, B. Danielewska-Nikiel, J.F. Borzelleca, G.W. Flamm, G.M. Williams, and T.C. Lines A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food Chem Toxicol 45 2007 2179 2205
12. P.C. Hollman, J.H. de Vries, S.D. van Leeuwen, M.J. Mengelers, and M.B. Katan Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers Am J Clin Nutr 62 1995 1276 1282
13. A.W. Boots, G.R. Haenen, and A. Bast Health effects of quercetin: from antioxidant to nutraceutical Eur J Pharmacol 585 2008 325 337
14. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am J Clin Nutr 79 2004 727 747
15. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am J Clin Nutr 81 2005 230S 242S
16. W. Mullen, J.M. Rouanet, C. Auger, P.L. Teissedre, S.T. Caldwell, and R.C. Hartley Bioavailability of [2-(14)C]quercetin-4′-glucoside in rats J Agric Food Chem 56 2008 12127 12137
17. M.R. Olthof, P.C. Hollman, M.N. Buijsman, J.M. van Amelsvoort, and M.B. Katan Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans J Nutr 133 2003 1806 1814
18. J.A. Conquer, G. Maiani, E. Azzini, A. Raguzzini, and B.J. Holub Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects J Nutr 128 1998 593 597
19. V.C. de Boer, A.A. Dihal, H. van der Woude, I.C. Arts, S. Wolffram, and G.M. Alink Tissue distribution of quercetin in rats and pigs J Nutr 135 2005 1718 1725
20. D. Pal, and A.K. Mitra MDR-and CYP3A4-mediated drug-herbal interactions Life Sci 78 2006 2131 2145
21. T. Okamoto Safety of quercetin for clinical application (Review) Int J Mol Med 16 2005 275 278
22. D.R. Ferry, A. Smith, J. Malkhandi, D.W. Fyfe, P.G. deTakats, and D. Anderson Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin Cancer Res 2 1996 659 668
23. D.W. Lamson, and M.S. Brignall Antioxidants and cancer, part 3: quercetin Altern Med Rev 5 2000 196 208
24. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study Lancet 342 1993 1007 1011
25. R.L. Edwards, T. Lyon, S.E. Litwin, A. Rabovsky, J.D. Symons, and T. Jalili Quercetin reduces blood pressure in hypertensive subjects J Nutr 137 2007 2405 2411
26. S. Egert, A. Bosy-Westphal, J. Seiberl, C. Kurbitz, U. Settler, and S. Plachta-Danielzik Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study Br J Nutr 102 2009 1065 1074
27. Overman A, Chuang CC, McIntosh M. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media. Int J Obes (Lond) 2011, doi:10.1038/ijo.2010.272 [Epub ahead of print].
28. C.C. Chuang, K. Martinez, G. Xie, A. Kennedy, A. Bumrungpert, and A. Overman Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes Am J Clin Nutr 92 2010 1511 1521
29. E. Youl, G. Bardy, R. Magous, G. Cros, F. Sejalon, and A. Virsolvy Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway Br J Pharmacol 161 2010 799 814
30. P.S. Prince, and B. Sathya Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats Eur J Pharmacol 635 2010 142 148
31. R. Kleemann, L. Verschuren, M. Morrison, S. Zadelaar, M.J. van Erk, and P.Y. Wielinga Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models Atherosclerosis 2011 10.1016/j.atherosclerosis.2011.04.023 [Epub ahead of print]
32. M. Ibarra, F. Perez-Vizcaino, A. Cogolludo, J. Duarte, F. Zaragoza-Arnaez, and J.G. Lopez-Lopez Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria Planta Med 68 2002 307 310
33. K. Ishizawa, M. Yoshizumi, Y. Kawai, J. Terao, Y. Kihira, and Y. Ikeda Pharmacology in health food: metabolism of quercetin in vivo and its protective effect against arteriosclerosis J Pharmacol Sci 115 2011 466 470
34. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
35. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
36. J.M. Gee, H. Hara, and I.T. Johnson Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats Nutr Cancer 43 2002 193 201
37. F. Casagrande, and J.M. Darbon Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1 Biochem Pharmacol 61 2001 1205 1215
38. R. Boly, T. Gras, T. Lamkami, P. Guissou, D. Serteyn, and R. Kiss Quercetin inhibwits a large panel of kinases implicated in cancer cell biology Int J Oncol 38 2011 833 842
39. J.A. Choi, J.Y. Kim, J.Y. Lee, C.M. Kang, H.J. Kwon, and Y.D. Yoo Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin Int J Oncol 19 2001 837 844
40. J.H. Jeong, J.Y. An, Y.T. Kwon, J.G. Rhee, and Y.J. Lee Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression J Cell Biochem 106 2009 73 82
41. J.H. Jung, J.O. Lee, J.H. Kim, S.K. Lee, G.Y. You, and S.H. Park Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation J Cell Physiol 223 2010 408 414
42. L.T. Lee, Y.T. Huang, J.J. Hwang, A.Y. Lee, F.C. Ke, and C.J. Huang Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells Biochem Pharmacol 67 2004 2103 2114
43. Y.T. Huang, J.J. Hwang, P.P. Lee, F.C. Ke, J.H. Huang, and C.J. Huang Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor Br J Pharmacol 128 1999 999 1010
44. F. Sicheri, I. Moarefi, and J. Kuriyan Crystal structure of the Src family tyrosine kinase Hck Nature 385 1997 602 609
45. N. Gulati, B. Laudet, V.M. Zohrabian, R. Murali, and M. Jhanwar-Uniyal The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway Anticancer Res 26 2006 1177 1181
46. K.W. Lee, N.J. Kang, Y.S. Heo, E.A. Rogozin, A. Pugliese, and M.K. Hwang Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine Cancer Res 68 2008 946 955
47. A.A. Dihal, H. van der Woude, P.J. Hendriksen, H. Charif, L.J. Dekker, and L. Ijsselstijn Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis Proteomics 8 2008 45 61
48. L.L. Zamin, E.C. Filippi-Chiela, P. Dillenburg-Pilla, F. Horn, C. Salbego, and G. Lenz Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells Cancer Sci 100 2009 1655 1662
49. D.T. Cosan, A. Soyocak, A. Basaran, I. Degirmenci, H.V. Gunes, and F.M. Sahin Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines Mol Biol Rep 38 2011 2463 2469
50. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
51. M. Russo, A. Mupo, C. Spagnuolo, and G.L. Russo Exploring death receptor pathways as selective targets in cancer therapy Biochem Pharmacol 80 2010 674 682
52. R.C. Taylor, S.P. Cullen, and S.J. Martin Apoptosis: controlled demolition at the cellular level Nat Rev Mol Cell Biol 9 2008 231 241
53. M. Russo, R. Palumbo, I. Tedesco, G. Mazzarella, P. Russo, and G. Iacomino Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line FEBS Lett 462 1999 322 328
54. M. Russo, R. Palumbo, A. Mupo, M. Tosto, G. Iacomino, and A. Scognamiglio Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Calpha Oncogene 22 2003 3330 3342
55. M. Russo, P. Nigro, R. Rosiello, R. D'Arienzo, and G.L. Russo Quercetin enhances CD95-and TRAIL-induced apoptosis in leukemia cell lines Leukemia 21 2007 1130 1133
56. Y.H. Kim, and Y.J. Lee TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation J Cell Biochem 100 2007 998 1009
57. M. Russo, C. Spagnuolo, S. Volpe, A. Mupo, I. Tedesco, and G.L. Russo Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients Br J Cancer 103 2010 642 648
58. M. Mouria, A.S. Gukovskaya, Y. Jung, P. Buechler, O.J. Hines, and H.A. Reber Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis Int J Cancer 98 2002 761 769
59. W. Zhou, G. Kallifatidis, B. Baumann, V. Rausch, J. Mattern, and J. Gladkich Dietary polyphenol quercetin targets pancreatic cancer stem cells Int J Oncol 37 2010 551 561
60. E.H. Walker, M.E. Pacold, O. Perisic, L. Stephens, P.T. Hawkins, and M.P. Wymann Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine Mol Cell 6 2000 909 919
61. K.W. Lee, S.G. Kim, H.P. Kim, E. Kwon, J. You, and H.J. Choi Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Cancer Res 68 2008 1916 1926
62. J.S. Duncan, J.P. Turowec, K.E. Duncan, G. Vilk, C. Wu, and B. Luscher A Peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling Sci Signal 4 2011 ra30
63. J.P. Spencer, C. Rice-Evans, and R.J. Williams Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability J Biol Chem 278 2003 34783 34793
64. S. Cheng, N. Gao, Z. Zhang, G. Chen, A. Budhraja, and Z. Ke Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax Clin Cancer Res 16 2010 5679 5691
65. C. Spagnuolo, C. Cerella, M. Russo, S. Chateauvieux, M. Diederich, and G.L. Russo Quercetin down-regulates Mcl-1 by acting on mRNA stability and protein degradation Br J Cancer 105 2011 221 230
66. C.H. Park, J.Y. Chang, E.R. Hahm, S. Park, H.K. Kim, and C.H. Yang Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells Biochem Biophys Res Commun 328 2005 227 234
67. J. Roman-Gomez, L. Cordeu, X. Agirre, A. Jimenez-Velasco, E. San Jose-Eneriz, and L. Garate Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia Blood 109 2007 3462 3469
68. F.H. Psahoulia, S. Moumtzi, M.L. Roberts, T. Sasazuki, S. Shirasawa, and A. Pintzas Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells Carcinogenesis 28 2007 1021 1031
69. R.L. Wiseman, Y. Zhang, K.P. Lee, H.P. Harding, C.M. Haynes, and J. Price Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1 Mol Cell 38 2010 291 304
70. W.F. Tan, L.P. Lin, M.H. Li, Y.X. Zhang, Y.G. Tong, and D. Xiao Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential Eur J Pharmacol 459 2003 255 262
71. S. Donnini, F. Finetti, L. Lusini, L. Morbidelli, V. Cheynier, and D. Barron Divergent effects of quercetin conjugates on angiogenesis Br J Nutr 95 2006 1016 1023
72. J.H. Bae, J.Y. Kim, M.J. Kim, S.H. Chang, Y.S. Park, and C.H. Son Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70 J Immunother 33 2010 391 401
73. K.A. O'Leary, S. de Pascual-Tereasa, P.W. Needs, Y.P. Bao, N.M. O'Brien, and G. Williamson Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription Mutat Res 551 2004 245 254
74. C.A. Warren, K.J. Paulhill, L.A. Davidson, J.R. Lupton, S.S. Taddeo, and M.Y. Hong Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis J Nutr 139 2009 101 105
75. G. Bobe, P.S. Albert, L.B. Sansbury, E. Lanza, A. Schatzkin, and N.H. Colburn Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial Cancer Prev Res (Phila) 3 2010 764 775
76. K. Senthilkumar, R. Arunkumar, P. Elumalai, G. Sharmila, D.N. Gunadharini, and S. Banudevi Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3) Cell Biochem Funct 29 2011 87 95
77. K. Phromnoi, S. Yodkeeree, S. Anuchapreeda, and P. Limtrakul Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids Acta Pharmacol Sin 30 2009 1169 1176
78. S. Fogarty, and D.G. Hardie Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim Biophys Acta 1804 2010 581 591
79. J.T. Hwang, D.Y. Kwon, and S.H. Yoon AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols N Biotechnol 26 2009 17 22
80. A.W. Boots, M. Drent, V.C. de Boer, A. Bast, and G.R. Haenen Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis Clin Nutr 30 2011 506 512
81. A. Scalbert, and G. Williamson Dietary intake and bioavailability of polyphenols J Nutr 130 2000 2073S 2085S
82. P.J. Mulholland, D.R. Ferry, D. Anderson, S.A. Hussain, A.M. Young, and J.E. Cook Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin Ann Oncol 12 2001 245 248
83. M.K. Kim, K.S. Park, W.S. Yeo, H. Choo, and Y. Chong In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates Bioorg Med Chem 17 2009 1164 1171
84. Z.P. Yuan, L.J. Chen, L.Y. Fan, M.H. Tang, G.L. Yang, and H.S. Yang Liposomal quercetin efficiently suppresses growth of solid tumors in murine models Clin Cancer Res 12 2006 3193 3199
85. A. Kumari, S.K. Yadav, Y.B. Pakade, B. Singh, and S.C. Yadav Development of biodegradable nanoparticles for delivery of quercetin Colloids Surf B Biointerfaces 80 2010 184 192
86. N.G. Sahoo, M. Kakran, L.A. Shaal, L. Li, R.H. Muller, and M. Pal Preparation and characterization of quercetin nanocrystals J Pharm Sci 100 2011 2379 2390
87. L.M. Howells, R.G. Britton, M. Mazzoletti, P. Greaves, M. Broggini, and K. Brown Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3′,4′,5′-trimethoxyflavonol, a quercetin analogue Cancer Prev Res (Phila) 3 2011 929 939
88. L. Biasutto, N. Sassi, A. Mattarei, E. Marotta, P. Cattelan, and A. Toninello Impact of mitochondriotropic quercetin derivatives on mitochondria Biochim Biophys Acta 1797 2010 189 196
89. R. Khonkarn, S. Mankhetkorn, W.E. Hennink, and S. Okonogi PEG-OCL micelles for quercetin solubilization and inhibition of cancer cell growth Eur J Pharm Biopharm 2011 10.1016/j.ejpb.2011.04.011 [Epub ahead of print]
90. de Mello Costa AR, Marquiafável FS, de Oliveira Lima Leite Vaz MM, Alves Rocha B, Pires Bueno PC, Amaral PL, da Silva Barud H, Berreta-Silva AA. Quercetin-PVP K25 solid dispersions. J Therm Anal Calorim 2011;104:273-8.
91. G.W. Peet, and J. Li IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin J Biol Chem 274 1999 32655 32661
92. I. Naasani, F. Oh-Hashi, T. Oh-Hara, W.Y. Feng, J. Johnston, and K. Chan Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo Cancer Res 63 2003 824 830
93. S. Sarno, E. de Moliner, M. Ruzzene, M.A. Pagano, R. Battistutta, and J. Bain Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin- 7-yl]acetic acid (IQA) Biochem J 374 2003 639 646
94. F. Jin, D.C. Nieman, R.A. Shanely, A.M. Knab, M.D. Austin, and W. Sha The variable plasma quercetin response to 12-week quercetin supplementation in humans Eur J Clin Nutr 64 2010 692 697
95. Y. Chen, P. Xiao, D.S. Ou-Yang, L. Fan, D. Guo, and Y.N. Wang Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers Clin Exp Pharmacol Physiol 36 2009 828 833
96. D.C. Nieman, D.A. Henson, K.R. Maxwell, A.S. Williams, S.R. McAnulty, and F. Jin Effects of quercetin and EGCG on mitochondrial biogenesis and immunity Med Sci Sports Exerc 41 2009 1467 1475
97. M.R. Olthof, P.C. Hollman, T.B. Vree, and M.B. Katan Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans J Nutr 130 2000 1200 1203
98. S. Egert, C. Boesch-Saadatmandi, S. Wolffram, G. Rimbach, and M.J. Muller Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype J Nutr 140 2009 278 284
99. S.A. Heinz, D.A. Henson, M.D. Austin, F. Jin, and D.C. Nieman Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial Pharmacol Res 62 2010 237 242
100. S.C. Bae, W.J. Jung, E.J. Lee, R. Yu, and M.K. Sung Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients J Am Coll Nutr 28 2009 56 62